Curia appoints Steve Lavezoli as Vice President of Biologics on Feb 26, bringing industry experience from Scorpius Biologics, Catalent Biologics, and Linde Gas.

Curia, a leading contract research, development, and manufacturing org, appoints Steve Lavezoli as Vice President of Biologics, effective Feb 26. He brings industry experience from Scorpius Biologics, Catalent Biologics, and Linde Gas. Curia, with 30+ years of experience & 27 global sites, focuses on life-changing therapies through biologics and small molecule offerings.